AAAAAA

   
Results: 1-9 |
Results: 9
BACTEREMIA AND SEVERE SEPSIS IN ADULTS - A MULTICENTER PROSPECTIVE SURVEY IN ICUS AND WARDS OF 24 HOSPITALS
Authors: BRUNBUISSON C DOYON F CARLET J BEDOCK B ANNONAY CH VALENTE E LESCALE O MISSET B CHARBONNEAU P VERGNAUD M COHEN R COLOIGNIER M FRANCES JL COMBES A DUVAL O DELLAMONICA P DESCAMPS JM DOMART Y GALIACY JL GOUIN F GUIVARCH G HENNEQUIN C KRAJEVITCH A DELMAS P HOLZAPFEL L LEPEU G LOIRAT P THALER F KNANI L MERCIER JC MOUTON Y LIBBRECHT E OFFENSTADT G PINAUD M PINSART M GIROU E PORTIER H GRAPPIN M REBEIX MT REGNIER B GACHOT B RICOME JL SOLLET JP MENTEC H TEMPELHOFF G BEURET P LEPOUTRE A
Citation: C. Brunbuisson et al., BACTEREMIA AND SEVERE SEPSIS IN ADULTS - A MULTICENTER PROSPECTIVE SURVEY IN ICUS AND WARDS OF 24 HOSPITALS, American journal of respiratory and critical care medicine, 154(3), 1996, pp. 617-624
EFFICACY OF SULBACTAM-AMPICILLIN COMBINATION IN THE TREATMENT OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA
Authors: HOLZAPFEL L FRAISSE F COULAUD JM CHAUVIN G GARRIGUES B VASQUEZ JL MICHAEL O
Citation: L. Holzapfel et al., EFFICACY OF SULBACTAM-AMPICILLIN COMBINATION IN THE TREATMENT OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA, Medecine et maladies infectieuses, 26, 1996, pp. 576-582
SINUS DIFFUSION OF TEICOPLANIN IN PATIENT S WITH NOSOCOMIAL SINUSITIS
Authors: HOLZAPFEL L VILLETTE P RACT C JEANNOT T HARLAY ML DEMINGEON G PIRALLA B
Citation: L. Holzapfel et al., SINUS DIFFUSION OF TEICOPLANIN IN PATIENT S WITH NOSOCOMIAL SINUSITIS, Medecine et maladies infectieuses, 25(8-9), 1995, pp. 940-944
SEVERE COMMUNITY-ACQUIRED PNEUMOCOCCAL PNEUMONIA
Authors: MOINE P VERCKEN JB CHEVRET S GAJDOS P SCHLEMMER B GARROUSTE MT MUIR JF DEFOUILLOY C THALER F TENAILLON A CARLET J TIMSIT JF VERCKEN JB GAJDOS P DEROHANCHABOT P BOLES JM OUTIN H TEMPE JD SCHNEIDER F HOLZAPFEL L SOLLET JP PETITPRETZ P FRAISSE F GBIKPIBENISSIAN G CARDINAUD JP BRUNBUISSON C
Citation: P. Moine et al., SEVERE COMMUNITY-ACQUIRED PNEUMOCOCCAL PNEUMONIA, Scandinavian journal of infectious diseases, 27(3), 1995, pp. 201-206
PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER CLINICAL-TRIAL
Authors: DHAINAUT JFA TENAILLON A LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP DEVATHAIRE F GUINOT P
Citation: Jfa. Dhainaut et al., PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER CLINICAL-TRIAL, Critical care medicine, 22(11), 1994, pp. 1720-1728
SEVERE COMMUNITY-ACQUIRED PNEUMONIA - ETIOLOGY, EPIDEMIOLOGY, AND PROGNOSIS FACTORS
Authors: MOINE P VERCKEN JB CHEVRET S CHASTANG C GAJDOS P SCHLEMMER B GARROUSTE MT MUIR JF DEFOUILLOY C THALER F TENAILLON A CARLET J TIMSIT JF DEROHANCHABOT P BOLES JM OUTIN H TEMPE JD SCHNEIDER F HOLZAPFEL L SOLLET JP PETITPRETZ P FRAISSE F GBIKPIBENISSIAN G CARDINAUD JP BRUNBUISSON C
Citation: P. Moine et al., SEVERE COMMUNITY-ACQUIRED PNEUMONIA - ETIOLOGY, EPIDEMIOLOGY, AND PROGNOSIS FACTORS, Chest, 105(5), 1994, pp. 1487-1495
INFLUENCE OF LONG-TERM OROTRACHEAL OR NASOTRACHEAL INTUBATION ON NOSOCOMIAL MAXILLARY SINUSITIS AND PNEUMONIA - RESULTS OF A PROSPECTIVE, RANDOMIZED, CLINICAL-TRIAL
Authors: HOLZAPFEL L CHEVRET S MADINIER G OHEN F DEMINGEON G COUPRY A CHAUDET M
Citation: L. Holzapfel et al., INFLUENCE OF LONG-TERM OROTRACHEAL OR NASOTRACHEAL INTUBATION ON NOSOCOMIAL MAXILLARY SINUSITIS AND PNEUMONIA - RESULTS OF A PROSPECTIVE, RANDOMIZED, CLINICAL-TRIAL, Critical care medicine, 21(8), 1993, pp. 1132-1138
EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS
Authors: TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P
Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 97-97
EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS
Authors: TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P
Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 196-196
Risultati: 1-9 |